Global Protein Therapeutics Market Size, Share & Industry Trends Analysis Report By Product, By Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders), By Regional Outlook and Forecast, 2022 - 2028

The Global Protein Therapeutics Market size is expected to reach $490.2 billion by 2028, rising at a market growth of 6.9% CAGR during the forecast period.

Protein therapeutic medicines are a class of pharmaceuticals used to treat a range of illnesses, including cancer, metabolic, hematological, immunological, hormonal, genetic, contagious diseases, and others. These medications could greatly enhance human health. Protein distribution in appropriate amounts to the body to enable the precise functioning of various glands, as well as other organs in the body, is the basic concept behind protein therapy, which is conceptually related to gene therapy.

Genetically modified versions of naturally produced human proteins are called therapeutic proteins. They can be utilized to swap out proteins that are defective or lacking in a particular condition. They can also increase the supply of a helpful protein, which helps lessen the effects of chemotherapy or sickness. The proteins produced by genetic engineering can be made to closely match the natural proteins they are meant to replace, or they can be improved by the addition of sugars and other compounds that prolong the protein's activity.

A protein that is defective or lacking in a certain condition can be replaced with therapeutic proteins. They can also increase the body's production of a helpful protein to lessen the effects of illness or chemotherapy. The proteins produced by genetic engineering may closely resemble the natural proteins they are intended to replace, or they may be improved.

COVID-19 Impact Analysis

The COVID-19 pandemic severely hampered the economy all over the world. A number of businesses were significantly demolished by the abrupt emergence of the pandemic. Moreover, several manufacturing and production facilities were closed owing to the outbreak due to the lockdown imposed by various governments within their countries. The protein therapeutics market was also disrupted in the initial period of the pandemic. Lockdown caused major delays within the development and delivery of crucial medical supplies. Attributed to this, the production of therapeutic protein was impeded.

Market Growth Factors

An increase in the cases of cancer across the world

One of the major factors that are driving the growth of the protein therapeutics market is the expansion in the prevalence of various types of cancer all over the world. Any disease that can affect any region of the body is referred to as cancer. Neoplasms and malignant tumors are other words that are used to denote this disease. One characteristic of cancer is the quick development of aberrant cells that expand outside of their normal borders, infiltrate other body components, and eventually move to other organs. This process is known as metastasis. The main reason why cancer patients die is because of widespread metastases within their bodies.

Rising focus of governments and regulatory bodies in accelerating the process of approval for this practice

A significant number of people in various developed, as well as developing nations who suffer from uncommon and complex diseases, depend on plasma-derived therapies every day as essential, life-saving medications. The need for these treatments, in particular immunoglobulins, has grown significantly and is still growing on a global scale. Plasma-derived therapies are treatments made from human plasma through a fractionation procedure in which the pertinent plasma proteins are isolated. The single largest component of human blood is called plasma, which is made up of proteins, salts, enzymes, and water. Primary and secondary immunodeficiencies, bleeding disorders, inhibitor deficiencies, and other rare diseases are all treated with plasma-derived medicines.

Market Restraining Factors

High manufacturing and administration cost

A major challenge in the growth of the protein therapeutics market is the high cost of protein therapies. Because of high product prices, some therapies that patients need for a speedy and complete recovery are no longer available. In several nations, prices are additionally governed by law. Through their authority over national healthcare organizations, which can cover a significant portion of the cost of distributing drugs to consumers, government bodies restrict costs.

Product Outlook

On the basis of Product, the Protein Therapeutics Market is segmented into Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone. In 2021, the Insulin segment garnered a significant revenue share of the protein therapeutics market. The rise in the growth of the segment is majorly attributed to the increasing cases of diabetes all over the world. Insulin is a natural hormone, which is produced by the pancreas. The lack of production of this hormone is the factor that stimulates the diabetes level of the human body.

Application Outlook

By application, the Protein Therapeutics Market is segregated into Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others. In 2021, the metabolic disorders segment procured the biggest revenue share of the protein therapeutics market. The rise in the growth of the segment is due to the exponential demand for high-quality medications and adaptable therapies for the treatment of diseases, particularly diabetes, which is anticipated to support the segment's growth.

Protein Therapeutics Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 282.4 Billion
Market size forecast in 2028	USD 490.2 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 6.9% from 2022 to 2028
Number of Pages	235
Number of Tables	344
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Product, Application, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	An increase in the cases of cancer across the world Rising focus of governments and regulatory bodies in accelerating the process of approval for this practice
Restraints	High manufacturing and administration cost

Regional Outlook

Region-wise, the Protein Therapeutics Market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In 2021, North America held the largest revenue share of the protein therapeutics market. This is ascribed to an increase in the incidence of chronic diseases, the use of cutting-edge treatments, the presence of important players, and an increase in healthcare spending in the area. Moreover, North American countries are early adopters of several new technologies and approaches.

Free Valuable Insights: Global Protein Therapeutics Market size to reach USD 490.2 Billion by 2028

KBV Cardinal Matrix - Protein Therapeutics Market Competition Analysis

The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; Johnson & Johnson and Pfizer, Inc. are the forerunners in the Protein Therapeutics Market. Companies such as Merck & Co., Inc. Amgen, Inc., Eli Lilly and Company are some of the key innovators in Protein Therapeutics Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Baxter International, Inc., Amgen, Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Merck & Co., Inc., Johnson & Johnson (Janssen Global Services, LLC), Pfizer, Inc., Novo Nordisk A/S and Sanofi S.A.

Strategies deployed in Protein Therapeutics Market

» Partnerships, Collaborations and Agreements:

• Aug-2022: Merck came into a collaboration with Orna Therapeutics, a biotechnology company. Following this collaboration, the companies would work on the discovery, development, and commercialization of multiple programs, encompassing therapeutics and vaccines in the sector of infectious disease and oncology.
• Mar-2022: Novo Nordisk joined hands with Massachusetts Institutes of Technology and Brigham and Women’s Hospital. Through this collaboration, the company aimed to leverage the distinct prospect to bring new transformational solutions to patients by utilizing its distinct capabilities.
• Jan-2022: Amgen teamed up with Amgen Generate Biomedicines, a therapeutics company. Under this collaboration, the companies aimed to develop and manufacture protein therapeutics to address 5 clinical ailments.
• Jan-2022: Merck teamed up with Absci, the drug, and target discovery company. Following this collaboration, Merck aimed to leverage Absci’s platform to utilize its compelling opportunity intending to develop new biologic candidates as well as explore complex protein expression.
• Aug-2021: Eli Lilly and Company joined hands with Lycia Therapeutics, a biotechnology company. Following this collaboration, the companies aimed to focus on the development, manufacturing, and marketing of new targeted therapeutics leveraging the proprietary lysosomal targeting chimera protein degradation technology of Lycia.
• Sep-2020: Merck collaborated with Seattle Genetics, an American biotechnology company. With this collaboration, the companies aimed to further expand the oncology portfolio of Merck in order to enhance the lives of cancer patients.

» Acquisitions and Mergers:

• Jun-2022: Pfizer took over ReViral, a privately held, clinical-stage biopharmaceutical company. Through this acquisition, the company aimed to integrate RSV investigational treatments of ReViral into its portfolio in order to acquire an offering of promising therapeutic candidates.
• Nov-2021: Pfizer took over Trillium Therapeutics, a clinical-stage immuno-oncology company. This acquisition aimed to offer an impressive portfolio, including biologics, to Pfizer
• Jul-2021: Amgen took over Teneobio, a clinical-stage biotechnology company. With this acquisition, the company aimed to leverage Teneobio's antibody platform in order to complement its prevailing capabilities. Moreover, the company also aimed to gain a diverse range of building blocks that can be created into new multispecific therapeutics.
• Jul-2021: Eli Lilly and Company completed its acquisition of Protomer, a pre-clinical stage biotechnology company. Under this acquisition, the company aimed to help Protomer in enhancing its diabetes range with its innovative technology.
• Feb-2021: Merck took over VelosBio, a privately held clinical-stage biopharmaceutical company. Through this acquisition, the company aimed to boost its expanding oncology portfolio while also strengthening its long-term growth potential.
• Aug-2020: Johnson & Johnson completed its acquisition of Momenta Pharmaceuticals, a biotechnology company. This acquisition aimed to strengthen Janssen’s position in the autoimmune diseases sector and offer a major catalyst for sustained growth of the company.

» Approvals and Trials:

• Sep-2020: Baxter International received the US FDA approval for its Clinimix and Clinimix E. The new formulations aimed to complement the offerings of medical formulations with their higher protein content.

Scope of the Study

Market Segments Covered in the Report:

By Product

• Monoclonal Antibodies
• Human Growth Hormone
• Fusion Protein
• Insulin
• Erythropoietin
• Interferon
• Follicle Stimulating Hormone

By Application

• Metabolic Disorders
• Immunologic Disorders
• Hematological Disorders
• Cancer
• Hormonal Disorders
• Genetic Disorders
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• Baxter International, Inc.
• Amgen, Inc.
• F. Hoffmann-La Roche Ltd.
• Eli Lilly And Company
• Merck & Co., Inc.
• Johnson & Johnson (Janssen Global Services, LLC)
• Pfizer, Inc.
• Novo Nordisk A/S
• Sanofi S.A.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Protein Therapeutics Market, by Product
1.4.2 Global Protein Therapeutics Market, by Application
1.4.3 Global Protein Therapeutics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Product Launches and Product Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2018, Mar – 2022, Jun) Leading Players

Chapter 4. Global Protein Therapeutics Market by Product
4.1 Global Monoclonal Antibodies Market by Region
4.2 Global Human Growth Hormone Market by Region
4.3 Global Fusion Protein Market by Region
4.4 Global Insulin Market by Region
4.5 Global Erythropoietin Market by Region
4.6 Global Interferon Market by Region
4.7 Global Follicle Stimulating Hormone Market by Region

Chapter 5. Global Protein Therapeutics Market by Application
5.1 Global Metabolic Disorders Market by Region
5.2 Global Immunologic Disorders Market by Region
5.3 Global Hematological Disorders Market by Region
5.4 Global Cancer Market by Region
5.5 Global Hormonal Disorders Market by Region
5.6 Global Genetic Disorders Market by Region
5.7 Global Others Market by Region

Chapter 6. Global Protein Therapeutics Market by Region
6.1 North America Protein Therapeutics Market
6.1.1 North America Protein Therapeutics Market by Product
6.1.1.1 North America Monoclonal Antibodies Market by Country
6.1.1.2 North America Human Growth Hormone Market by Country
6.1.1.3 North America Fusion Protein Market by Country
6.1.1.4 North America Insulin Market by Country
6.1.1.5 North America Erythropoietin Market by Country
6.1.1.6 North America Interferon Market by Country
6.1.1.7 North America Follicle Stimulating Hormone Market by Country
6.1.2 North America Protein Therapeutics Market by Application
6.1.2.1 North America Metabolic Disorders Market by Country
6.1.2.2 North America Immunologic Disorders Market by Country
6.1.2.3 North America Hematological Disorders Market by Country
6.1.2.4 North America Cancer Market by Country
6.1.2.5 North America Hormonal Disorders Market by Country
6.1.2.6 North America Genetic Disorders Market by Country
6.1.2.7 North America Others Market by Country
6.1.3 North America Protein Therapeutics Market by Country
6.1.3.1 US Protein Therapeutics Market
6.1.3.1.1 US Protein Therapeutics Market by Product
6.1.3.1.2 US Protein Therapeutics Market by Application
6.1.3.2 Canada Protein Therapeutics Market
6.1.3.2.1 Canada Protein Therapeutics Market by Product
6.1.3.2.2 Canada Protein Therapeutics Market by Application
6.1.3.3 Mexico Protein Therapeutics Market
6.1.3.3.1 Mexico Protein Therapeutics Market by Product
6.1.3.3.2 Mexico Protein Therapeutics Market by Application
6.1.3.4 Rest of North America Protein Therapeutics Market
6.1.3.4.1 Rest of North America Protein Therapeutics Market by Product
6.1.3.4.2 Rest of North America Protein Therapeutics Market by Application
6.2 Europe Protein Therapeutics Market
6.2.1 Europe Protein Therapeutics Market by Product
6.2.1.1 Europe Monoclonal Antibodies Market by Country
6.2.1.2 Europe Human Growth Hormone Market by Country
6.2.1.3 Europe Fusion Protein Market by Country
6.2.1.4 Europe Insulin Market by Country
6.2.1.5 Europe Erythropoietin Market by Country
6.2.1.6 Europe Interferon Market by Country
6.2.1.7 Europe Follicle Stimulating Hormone Market by Country
6.2.2 Europe Protein Therapeutics Market by Application
6.2.2.1 Europe Metabolic Disorders Market by Country
6.2.2.2 Europe Immunologic Disorders Market by Country
6.2.2.3 Europe Hematological Disorders Market by Country
6.2.2.4 Europe Cancer Market by Country
6.2.2.5 Europe Hormonal Disorders Market by Country
6.2.2.6 Europe Genetic Disorders Market by Country
6.2.2.7 Europe Others Market by Country
6.2.3 Europe Protein Therapeutics Market by Country
6.2.3.1 Germany Protein Therapeutics Market
6.2.3.1.1 Germany Protein Therapeutics Market by Product
6.2.3.1.2 Germany Protein Therapeutics Market by Application
6.2.3.2 UK Protein Therapeutics Market
6.2.3.2.1 UK Protein Therapeutics Market by Product
6.2.3.2.2 UK Protein Therapeutics Market by Application
6.2.3.3 France Protein Therapeutics Market
6.2.3.3.1 France Protein Therapeutics Market by Product
6.2.3.3.2 France Protein Therapeutics Market by Application
6.2.3.4 Russia Protein Therapeutics Market
6.2.3.4.1 Russia Protein Therapeutics Market by Product
6.2.3.4.2 Russia Protein Therapeutics Market by Application
6.2.3.5 Spain Protein Therapeutics Market
6.2.3.5.1 Spain Protein Therapeutics Market by Product
6.2.3.5.2 Spain Protein Therapeutics Market by Application
6.2.3.6 Italy Protein Therapeutics Market
6.2.3.6.1 Italy Protein Therapeutics Market by Product
6.2.3.6.2 Italy Protein Therapeutics Market by Application
6.2.3.7 Rest of Europe Protein Therapeutics Market
6.2.3.7.1 Rest of Europe Protein Therapeutics Market by Product
6.2.3.7.2 Rest of Europe Protein Therapeutics Market by Application
6.3 Asia Pacific Protein Therapeutics Market
6.3.1 Asia Pacific Protein Therapeutics Market by Product
6.3.1.1 Asia Pacific Monoclonal Antibodies Market by Country
6.3.1.2 Asia Pacific Human Growth Hormone Market by Country
6.3.1.3 Asia Pacific Fusion Protein Market by Country
6.3.1.4 Asia Pacific Insulin Market by Country
6.3.1.5 Asia Pacific Erythropoietin Market by Country
6.3.1.6 Asia Pacific Interferon Market by Country
6.3.1.7 Asia Pacific Follicle Stimulating Hormone Market by Country
6.3.2 Asia Pacific Protein Therapeutics Market by Application
6.3.2.1 Asia Pacific Metabolic Disorders Market by Country
6.3.2.2 Asia Pacific Immunologic Disorders Market by Country
6.3.2.3 Asia Pacific Hematological Disorders Market by Country
6.3.2.4 Asia Pacific Cancer Market by Country
6.3.2.5 Asia Pacific Hormonal Disorders Market by Country
6.3.2.6 Asia Pacific Genetic Disorders Market by Country
6.3.2.7 Asia Pacific Others Market by Country
6.3.3 Asia Pacific Protein Therapeutics Market by Country
6.3.3.1 China Protein Therapeutics Market
6.3.3.1.1 China Protein Therapeutics Market by Product
6.3.3.1.2 China Protein Therapeutics Market by Application
6.3.3.2 Japan Protein Therapeutics Market
6.3.3.2.1 Japan Protein Therapeutics Market by Product
6.3.3.2.2 Japan Protein Therapeutics Market by Application
6.3.3.3 India Protein Therapeutics Market
6.3.3.3.1 India Protein Therapeutics Market by Product
6.3.3.3.2 India Protein Therapeutics Market by Application
6.3.3.4 South Korea Protein Therapeutics Market
6.3.3.4.1 South Korea Protein Therapeutics Market by Product
6.3.3.4.2 South Korea Protein Therapeutics Market by Application
6.3.3.5 Singapore Protein Therapeutics Market
6.3.3.5.1 Singapore Protein Therapeutics Market by Product
6.3.3.5.2 Singapore Protein Therapeutics Market by Application
6.3.3.6 Malaysia Protein Therapeutics Market
6.3.3.6.1 Malaysia Protein Therapeutics Market by Product
6.3.3.6.2 Malaysia Protein Therapeutics Market by Application
6.3.3.7 Rest of Asia Pacific Protein Therapeutics Market
6.3.3.7.1 Rest of Asia Pacific Protein Therapeutics Market by Product
6.3.3.7.2 Rest of Asia Pacific Protein Therapeutics Market by Application
6.4 LAMEA Protein Therapeutics Market
6.4.1 LAMEA Protein Therapeutics Market by Product
6.4.1.1 LAMEA Monoclonal Antibodies Market by Country
6.4.1.2 LAMEA Human Growth Hormone Market by Country
6.4.1.3 LAMEA Fusion Protein Market by Country
6.4.1.4 LAMEA Insulin Market by Country
6.4.1.5 LAMEA Erythropoietin Market by Country
6.4.1.6 LAMEA Interferon Market by Country
6.4.1.7 LAMEA Follicle Stimulating Hormone Market by Country
6.4.2 LAMEA Protein Therapeutics Market by Application
6.4.2.1 LAMEA Metabolic Disorders Market by Country
6.4.2.2 LAMEA Immunologic Disorders Market by Country
6.4.2.3 LAMEA Hematological Disorders Market by Country
6.4.2.4 LAMEA Cancer Market by Country
6.4.2.5 LAMEA Hormonal Disorders Market by Country
6.4.2.6 LAMEA Genetic Disorders Market by Country
6.4.2.7 LAMEA Others Market by Country
6.4.3 LAMEA Protein Therapeutics Market by Country
6.4.3.1 Brazil Protein Therapeutics Market
6.4.3.1.1 Brazil Protein Therapeutics Market by Product
6.4.3.1.2 Brazil Protein Therapeutics Market by Application
6.4.3.2 Argentina Protein Therapeutics Market
6.4.3.2.1 Argentina Protein Therapeutics Market by Product
6.4.3.2.2 Argentina Protein Therapeutics Market by Application
6.4.3.3 UAE Protein Therapeutics Market
6.4.3.3.1 UAE Protein Therapeutics Market by Product
6.4.3.3.2 UAE Protein Therapeutics Market by Application
6.4.3.4 Saudi Arabia Protein Therapeutics Market
6.4.3.4.1 Saudi Arabia Protein Therapeutics Market by Product
6.4.3.4.2 Saudi Arabia Protein Therapeutics Market by Application
6.4.3.5 South Africa Protein Therapeutics Market
6.4.3.5.1 South Africa Protein Therapeutics Market by Product
6.4.3.5.2 South Africa Protein Therapeutics Market by Application
6.4.3.6 Nigeria Protein Therapeutics Market
6.4.3.6.1 Nigeria Protein Therapeutics Market by Product
6.4.3.6.2 Nigeria Protein Therapeutics Market by Application
6.4.3.7 Rest of LAMEA Protein Therapeutics Market
6.4.3.7.1 Rest of LAMEA Protein Therapeutics Market by Product
6.4.3.7.2 Rest of LAMEA Protein Therapeutics Market by Application

Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Baxter International, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.2.5.2 Acquisition and Mergers:
7.3 Amgen, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.3.5.2 Acquisition and Mergers:
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Eli Lilly And Company
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Acquisition and Mergers:
7.6 Merck & Co., Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Acquisition and Mergers:
7.7 Johnson & Johnson (Janssen Global Services, LLC)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental &Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.7.5.2 Acquisition and Mergers:
7.8 Pfizer, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional & Segmental Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.9 Novo Nordisk A/S
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental & Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.10. Sanofi S.A.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense

TABLE 1 Global Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 Global Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Protein Therapeutics Market
TABLE 4 Product Launches And Product Expansions– Protein Therapeutics Market
TABLE 5 Acquisition and Mergers– Protein Therapeutics Market
TABLE 6 Trial and Approvals– Protein Therapeutics Market
TABLE 7 Global Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 8 Global Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 9 Global Monoclonal Antibodies Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Monoclonal Antibodies Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Human Growth Hormone Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Human Growth Hormone Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Fusion Protein Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Fusion Protein Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Insulin Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Insulin Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Erythropoietin Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Erythropoietin Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Interferon Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Interferon Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Follicle Stimulating Hormone Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Follicle Stimulating Hormone Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 24 Global Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 25 Global Metabolic Disorders Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Metabolic Disorders Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Immunologic Disorders Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Immunologic Disorders Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Hematological Disorders Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Hematological Disorders Market by Region, 2022 - 2028, USD Million
TABLE 31 Global Cancer Market by Region, 2018 - 2021, USD Million
TABLE 32 Global Cancer Market by Region, 2022 - 2028, USD Million
TABLE 33 Global Hormonal Disorders Market by Region, 2018 - 2021, USD Million
TABLE 34 Global Hormonal Disorders Market by Region, 2022 - 2028, USD Million
TABLE 35 Global Genetic Disorders Market by Region, 2018 - 2021, USD Million
TABLE 36 Global Genetic Disorders Market by Region, 2022 - 2028, USD Million
TABLE 37 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 38 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 39 Global Protein Therapeutics Market by Region, 2018 - 2021, USD Million
TABLE 40 Global Protein Therapeutics Market by Region, 2022 - 2028, USD Million
TABLE 41 North America Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 42 North America Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 43 North America Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 44 North America Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 45 North America Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Human Growth Hormone Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Human Growth Hormone Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Fusion Protein Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Fusion Protein Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Insulin Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Insulin Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Interferon Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Interferon Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 60 North America Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 61 North America Metabolic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 62 North America Metabolic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 63 North America Immunologic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 64 North America Immunologic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 65 North America Hematological Disorders Market by Country, 2018 - 2021, USD Million
TABLE 66 North America Hematological Disorders Market by Country, 2022 - 2028, USD Million
TABLE 67 North America Cancer Market by Country, 2018 - 2021, USD Million
TABLE 68 North America Cancer Market by Country, 2022 - 2028, USD Million
TABLE 69 North America Hormonal Disorders Market by Country, 2018 - 2021, USD Million
TABLE 70 North America Hormonal Disorders Market by Country, 2022 - 2028, USD Million
TABLE 71 North America Genetic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 72 North America Genetic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 73 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 74 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 75 North America Protein Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 76 North America Protein Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 77 US Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 78 US Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 79 US Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 80 US Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 81 US Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 82 US Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 83 Canada Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 84 Canada Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 85 Canada Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 86 Canada Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 87 Canada Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 88 Canada Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 89 Mexico Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 90 Mexico Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 91 Mexico Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 92 Mexico Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 93 Mexico Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 94 Mexico Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 95 Rest of North America Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 96 Rest of North America Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 97 Rest of North America Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 98 Rest of North America Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 99 Rest of North America Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 100 Rest of North America Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 101 Europe Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 102 Europe Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 103 Europe Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 104 Europe Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 105 Europe Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
TABLE 106 Europe Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
TABLE 107 Europe Human Growth Hormone Market by Country, 2018 - 2021, USD Million
TABLE 108 Europe Human Growth Hormone Market by Country, 2022 - 2028, USD Million
TABLE 109 Europe Fusion Protein Market by Country, 2018 - 2021, USD Million
TABLE 110 Europe Fusion Protein Market by Country, 2022 - 2028, USD Million
TABLE 111 Europe Insulin Market by Country, 2018 - 2021, USD Million
TABLE 112 Europe Insulin Market by Country, 2022 - 2028, USD Million
TABLE 113 Europe Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 114 Europe Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 115 Europe Interferon Market by Country, 2018 - 2021, USD Million
TABLE 116 Europe Interferon Market by Country, 2022 - 2028, USD Million
TABLE 117 Europe Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
TABLE 118 Europe Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
TABLE 119 Europe Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 120 Europe Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 121 Europe Metabolic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 122 Europe Metabolic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 123 Europe Immunologic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 124 Europe Immunologic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 125 Europe Hematological Disorders Market by Country, 2018 - 2021, USD Million
TABLE 126 Europe Hematological Disorders Market by Country, 2022 - 2028, USD Million
TABLE 127 Europe Cancer Market by Country, 2018 - 2021, USD Million
TABLE 128 Europe Cancer Market by Country, 2022 - 2028, USD Million
TABLE 129 Europe Hormonal Disorders Market by Country, 2018 - 2021, USD Million
TABLE 130 Europe Hormonal Disorders Market by Country, 2022 - 2028, USD Million
TABLE 131 Europe Genetic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 132 Europe Genetic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 133 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 134 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 135 Europe Protein Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 136 Europe Protein Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 137 Germany Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 138 Germany Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 139 Germany Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 140 Germany Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 141 Germany Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 142 Germany Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 143 UK Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 144 UK Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 145 UK Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 146 UK Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 147 UK Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 148 UK Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 149 France Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 150 France Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 151 France Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 152 France Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 153 France Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 154 France Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 155 Russia Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 156 Russia Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 157 Russia Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 158 Russia Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 159 Russia Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 160 Russia Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 161 Spain Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 162 Spain Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 163 Spain Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 164 Spain Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 165 Spain Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 166 Spain Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 167 Italy Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 168 Italy Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 169 Italy Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 170 Italy Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 171 Italy Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 172 Italy Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 173 Rest of Europe Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 174 Rest of Europe Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 175 Rest of Europe Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 176 Rest of Europe Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 177 Rest of Europe Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 178 Rest of Europe Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 179 Asia Pacific Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 180 Asia Pacific Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 181 Asia Pacific Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 182 Asia Pacific Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 183 Asia Pacific Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
TABLE 184 Asia Pacific Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
TABLE 185 Asia Pacific Human Growth Hormone Market by Country, 2018 - 2021, USD Million
TABLE 186 Asia Pacific Human Growth Hormone Market by Country, 2022 - 2028, USD Million
TABLE 187 Asia Pacific Fusion Protein Market by Country, 2018 - 2021, USD Million
TABLE 188 Asia Pacific Fusion Protein Market by Country, 2022 - 2028, USD Million
TABLE 189 Asia Pacific Insulin Market by Country, 2018 - 2021, USD Million
TABLE 190 Asia Pacific Insulin Market by Country, 2022 - 2028, USD Million
TABLE 191 Asia Pacific Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 192 Asia Pacific Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 193 Asia Pacific Interferon Market by Country, 2018 - 2021, USD Million
TABLE 194 Asia Pacific Interferon Market by Country, 2022 - 2028, USD Million
TABLE 195 Asia Pacific Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
TABLE 196 Asia Pacific Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
TABLE 197 Asia Pacific Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 198 Asia Pacific Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 199 Asia Pacific Metabolic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 200 Asia Pacific Metabolic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 201 Asia Pacific Immunologic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 202 Asia Pacific Immunologic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 203 Asia Pacific Hematological Disorders Market by Country, 2018 - 2021, USD Million
TABLE 204 Asia Pacific Hematological Disorders Market by Country, 2022 - 2028, USD Million
TABLE 205 Asia Pacific Cancer Market by Country, 2018 - 2021, USD Million
TABLE 206 Asia Pacific Cancer Market by Country, 2022 - 2028, USD Million
TABLE 207 Asia Pacific Hormonal Disorders Market by Country, 2018 - 2021, USD Million
TABLE 208 Asia Pacific Hormonal Disorders Market by Country, 2022 - 2028, USD Million
TABLE 209 Asia Pacific Genetic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 210 Asia Pacific Genetic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 211 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 212 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 213 Asia Pacific Protein Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 214 Asia Pacific Protein Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 215 China Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 216 China Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 217 China Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 218 China Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 219 China Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 220 China Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 221 Japan Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 222 Japan Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 223 Japan Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 224 Japan Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 225 Japan Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 226 Japan Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 227 India Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 228 India Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 229 India Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 230 India Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 231 India Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 232 India Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 233 South Korea Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 234 South Korea Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 235 South Korea Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 236 South Korea Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 237 South Korea Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 238 South Korea Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 239 Singapore Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 240 Singapore Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 241 Singapore Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 242 Singapore Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 243 Singapore Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 244 Singapore Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 245 Malaysia Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 246 Malaysia Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 247 Malaysia Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 248 Malaysia Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 249 Malaysia Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 250 Malaysia Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 251 Rest of Asia Pacific Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 252 Rest of Asia Pacific Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 253 Rest of Asia Pacific Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 254 Rest of Asia Pacific Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 255 Rest of Asia Pacific Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 256 Rest of Asia Pacific Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 257 LAMEA Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 258 LAMEA Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 259 LAMEA Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 260 LAMEA Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 261 LAMEA Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
TABLE 262 LAMEA Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
TABLE 263 LAMEA Human Growth Hormone Market by Country, 2018 - 2021, USD Million
TABLE 264 LAMEA Human Growth Hormone Market by Country, 2022 - 2028, USD Million
TABLE 265 LAMEA Fusion Protein Market by Country, 2018 - 2021, USD Million
TABLE 266 LAMEA Fusion Protein Market by Country, 2022 - 2028, USD Million
TABLE 267 LAMEA Insulin Market by Country, 2018 - 2021, USD Million
TABLE 268 LAMEA Insulin Market by Country, 2022 - 2028, USD Million
TABLE 269 LAMEA Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 270 LAMEA Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 271 LAMEA Interferon Market by Country, 2018 - 2021, USD Million
TABLE 272 LAMEA Interferon Market by Country, 2022 - 2028, USD Million
TABLE 273 LAMEA Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
TABLE 274 LAMEA Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
TABLE 275 LAMEA Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 276 LAMEA Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 277 LAMEA Metabolic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 278 LAMEA Metabolic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 279 LAMEA Immunologic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 280 LAMEA Immunologic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 281 LAMEA Hematological Disorders Market by Country, 2018 - 2021, USD Million
TABLE 282 LAMEA Hematological Disorders Market by Country, 2022 - 2028, USD Million
TABLE 283 LAMEA Cancer Market by Country, 2018 - 2021, USD Million
TABLE 284 LAMEA Cancer Market by Country, 2022 - 2028, USD Million
TABLE 285 LAMEA Hormonal Disorders Market by Country, 2018 - 2021, USD Million
TABLE 286 LAMEA Hormonal Disorders Market by Country, 2022 - 2028, USD Million
TABLE 287 LAMEA Genetic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 288 LAMEA Genetic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 289 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 290 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 291 LAMEA Protein Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 292 LAMEA Protein Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 293 Brazil Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 294 Brazil Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 295 Brazil Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 296 Brazil Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 297 Brazil Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 298 Brazil Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 299 Argentina Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 300 Argentina Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 301 Argentina Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 302 Argentina Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 303 Argentina Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 304 Argentina Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 305 UAE Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 306 UAE Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 307 UAE Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 308 UAE Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 309 UAE Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 310 UAE Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 311 Saudi Arabia Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 312 Saudi Arabia Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 313 Saudi Arabia Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 314 Saudi Arabia Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 315 Saudi Arabia Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 316 Saudi Arabia Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 317 South Africa Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 318 South Africa Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 319 South Africa Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 320 South Africa Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 321 South Africa Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 322 South Africa Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 323 Nigeria Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 324 Nigeria Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 325 Nigeria Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 326 Nigeria Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 327 Nigeria Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 328 Nigeria Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 329 Rest of LAMEA Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 330 Rest of LAMEA Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 331 Rest of LAMEA Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 332 Rest of LAMEA Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 333 Rest of LAMEA Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 334 Rest of LAMEA Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 335 Key Information – Abbott Laboratories
TABLE 336 Key Information – Baxter International, Inc.
TABLE 337 Key Information – Amgen, Inc.
TABLE 338 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 339 Key Information – Eli Lilly And Company
TABLE 340 KEY INFORMATION - MERCK & CO., INC.
TABLE 341 Key information –Johnson & Johnson
TABLE 342 Key Information – Pfizer, Inc.
TABLE 343 Key information – Novo Nordisk A/S
TABLE 344 Key Information – Sanofi S.A.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Acquisition and Mergers: 2018, Mar – 2022, Jun) Leading Players
FIG 5 Global Protein Therapeutics Market Share by Product, 2021
FIG 6 Global Protein Therapeutics Market Share by Product, 2028
FIG 7 Global Protein Therapeutics Market by Product, 2018 - 2028, USD Million
FIG 8 Global Protein Therapeutics Market Share by Application, 2021
FIG 9 Global Protein Therapeutics Market Share by Application, 2028
FIG 10 Global Protein Therapeutics Market by Application, 2018 - 2028, USD Million
FIG 11 Global Protein Therapeutics Market Share by Region, 2021
FIG 12 Global Protein Therapeutics Market Share by Region, 2028
FIG 13 Global Protein Therapeutics Market by Region, 2018 - 2028, USD Million
FIG 14 Swot analysis: Abbott laboratories
FIG 15 Recent strategies and developments: Merck & Co., Inc.